"According to UN calculations, 74 million women worldwide and 3.1% of UK women aged 15-49 use injectable contraception. Multiple studies have shown that women who take Depo-Provera have a much higher relative risk of developing meningiomas, though the overall risk remains low. Not normally cancerous, these benign tumours can cause seizures, blindness, hearing loss, headaches and memory problems. Now several law firms are hoping to take legal action against Pfizer in the UK."
"We have been approached by at least 30 women who have developed meningiomas following prolonged use of Depo-Provera. Their lives have been considerably impacted due to having brain tumours, with consequences such as loss of vision and, in one case, a woman having to terminate her pregnancy. The duty here lies with Pfizer to ensure a drug is safe and to update warnings and contraindications as soon as new risks become known."
Depo-Provera is a high-dose synthetic progesterone given by injection every three months for contraception and menstrual symptoms. UN estimates indicate 74 million women worldwide and 3.1% of UK women aged 15–49 use injectable contraception. Multiple studies show a substantially higher relative risk of developing meningiomas among Depo-Provera users, though absolute risk remains low. Meningiomas are usually benign but can cause seizures, blindness, hearing loss, headaches and memory problems. Several UK law firms are evaluating potential claims against Pfizer after dozens of women reported meningiomas following prolonged Depo-Provera use, and firms are assessing legal merits and safety warnings.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]